In a similar study, 9 out of 14 patients with a confirmed diagnosis of stage IIIB–IV NSCLC, naïve or under treatment with a known ALK status, were found positive for EML4-ALK in RNA isolated from exosomes using NGS [212]. The gene discussed is EML4; the disease is non-small cell lung carcinoma.